OnKure Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OnKure Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10688
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OnKure Inc (OnKure) is a drug developer that discovers and develops epigenetic therapies for the treatment of cancer. The company offers production of specific histone deacetylases inhibitors. Its lead product candidate ONK102 significantly reduces the growth rate of tumors in hematological and solid tumor cancers, when dosed by itself or in combination with other targeted therapies. The company also discovers HDAC 6 inhibitors that are among the most potent and selective agents. It collaborates with veteran consultants and advisors for pre-clinical and clinical development activities. OnKure is headquartered in Longmont, Colorado, the US.

OnKure Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OnKure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OnKure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OnKure Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
OnKure Raises USD7 Million in Series A Financing 10
OnKure Raises USD0.5 Million in Financing 11
Onkure Raises US$0.6 Million In Venture Financing 12
OnKure Raises US$0.5 Million In Venture Financing 13
OnKure Inc – Key Competitors 14
OnKure Inc – Key Employees 15
OnKure Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
OnKure Inc, Pharmaceuticals & Healthcare, Key Facts 2
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OnKure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OnKure Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OnKure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OnKure Raises USD7 Million in Series A Financing 10
OnKure Raises USD0.5 Million in Financing 11
Onkure Raises US$0.6 Million In Venture Financing 12
OnKure Raises US$0.5 Million In Venture Financing 13
OnKure Inc, Key Competitors 14
OnKure Inc, Key Employees 15

List of Figures
OnKure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OnKure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OnKure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[OnKure Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Phillips 66 Co (PSX)-石油・ガス分野:企業M&A・提携分析
    Summary Phillips 66 Company (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants, and transports, fractionates and markets natural gas liquids …
  • IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Jiangsu Nhwa Pharmaceutical Corp Ltd (002262)-製薬・医療分野:企業M&A・提携分析
    Summary Jiangsu Nhwa Pharmaceutical Corp Ltd (Jiangsu) is a pharmaceutical company that research, develops and manufactures central nervous system medicines. The company offers psychiatrical, anesthetic and neurological medicines including anti-anxiety agent, anti-psychopathic drug, antiepileptic dr …
  • Applied Genetic Technologies Corp (AGTC):製薬・医療:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • Rohto Pharmaceutical Co Ltd (4527):製薬・医療:M&Aディール及び事業提携情報
    Summary Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) is a pharmaceutical company that manufactures and markets cosmetics and functional foods. The company offers products such as eye care products, skin care products, oral medicine product, cosmetics, eye drops, gastrointestinal medicines, der …
  • Daimler AG (DAI):電力:M&Aディール及び事業提携情報
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • Reliance Steel & Aluminum Co:戦略・SWOT・企業財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Owens & Minor Inc (OMI):企業の財務・戦略的SWOT分析
    Owens & Minor Inc (OMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Intrepid Mines Limited:企業の戦略・SWOT・財務情報
    Intrepid Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Intrepid Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Axela Inc:製品パイプライン分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • POSCO ICT Company Ltd. (022100):企業の財務・戦略的SWOT分析
    POSCO ICT Company Ltd. (022100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TES Aviation Group:企業の戦略・SWOT・財務情報
    TES Aviation Group - Strategy, SWOT and Corporate Finance Report Summary TES Aviation Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sanofi Pasteur SA-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi Pasteur SA (Sanofi Pasteur), formerly Aventis Pasteur SA, a subsidiary of Sanofi, is a manufacturer and marketer of vaccines against bacterial and viral diseases. The company provides meningococcal vaccines and seasonal influenza vaccines. Its products are used in the treatment of cho …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務情報
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Great Southern Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Radboud University Nijmegen Medical Centre-製薬・医療分野:企業M&A・提携分析
    Summary Radboud University Nijmegen Medical Centre (Radboud UMC), a subsidiary of Radboud University is a university medical center that offers patient care, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and trans …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆